T. Rowe Price Associates’s Prestige Consumer Healthcare PBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$42.5M Buy
531,609
+65,405
+14% +$5.22M ﹤0.01% 771
2025
Q1
$40.1M Buy
466,204
+11,112
+2% +$955K ﹤0.01% 786
2024
Q4
$35.5M Buy
455,092
+1,686
+0.4% +$132K ﹤0.01% 855
2024
Q3
$32.7M Buy
453,406
+7,496
+2% +$540K ﹤0.01% 869
2024
Q2
$30.7M Buy
445,910
+79,751
+22% +$5.49M ﹤0.01% 847
2024
Q1
$26.6M Sell
366,159
-39,130
-10% -$2.84M ﹤0.01% 904
2023
Q4
$24.8M Sell
405,289
-2,014
-0.5% -$123K ﹤0.01% 901
2023
Q3
$23.3M Buy
407,303
+2,027
+0.5% +$116K ﹤0.01% 878
2023
Q2
$24.1M Buy
405,276
+7,095
+2% +$422K ﹤0.01% 885
2023
Q1
$24.9M Buy
398,181
+234,963
+144% +$14.7M ﹤0.01% 858
2022
Q4
$10.2M Buy
163,218
+111,046
+213% +$6.95M ﹤0.01% 1050
2022
Q3
$2.6M Buy
52,172
+5,480
+12% +$273K ﹤0.01% 1358
2022
Q2
$2.75M Sell
46,692
-2,961
-6% -$174K ﹤0.01% 1528
2022
Q1
$2.63M Buy
49,653
+5,893
+13% +$312K ﹤0.01% 1595
2021
Q4
$2.65M Buy
43,760
+4,431
+11% +$269K ﹤0.01% 1612
2021
Q3
$2.21M Buy
39,329
+3,406
+9% +$191K ﹤0.01% 1685
2021
Q2
$1.87M Sell
35,923
-5,122
-12% -$267K ﹤0.01% 1761
2021
Q1
$1.81M Buy
41,045
+706
+2% +$31.1K ﹤0.01% 1764
2020
Q4
$1.41M Sell
40,339
-670,161
-94% -$23.4M ﹤0.01% 1780
2020
Q3
$25.9M Buy
710,500
+3,247
+0.5% +$118K ﹤0.01% 1080
2020
Q2
$26.6M Buy
707,253
+453
+0.1% +$17K ﹤0.01% 1051
2020
Q1
$25.9M Sell
706,800
-153,962
-18% -$5.65M ﹤0.01% 988
2019
Q4
$34.9M Sell
860,762
-61,101
-7% -$2.47M ﹤0.01% 1023
2019
Q3
$32M Sell
921,863
-12,454
-1% -$432K ﹤0.01% 1014
2019
Q2
$29.6M Sell
934,317
-1,222,859
-57% -$38.7M ﹤0.01% 1056
2019
Q1
$64.5M Sell
2,157,176
-305,772
-12% -$9.15M 0.01% 776
2018
Q4
$76.1M Buy
2,462,948
+55,034
+2% +$1.7M 0.01% 678
2018
Q3
$91.2M Buy
2,407,914
+398,813
+20% +$15.1M 0.01% 700
2018
Q2
$77.1M Buy
2,009,101
+652,319
+48% +$25M 0.01% 743
2018
Q1
$45.8M Buy
1,356,782
+511,091
+60% +$17.2M 0.01% 907
2017
Q4
$37.6M Buy
845,691
+4,134
+0.5% +$184K 0.01% 972
2017
Q3
$42.2M Buy
841,557
+60,212
+8% +$3.02M 0.01% 914
2017
Q2
$41.3M Buy
781,345
+43,348
+6% +$2.29M 0.01% 903
2017
Q1
$41M Buy
737,997
+69,950
+10% +$3.89M 0.01% 880
2016
Q4
$34.8M Sell
668,047
-5,080
-0.8% -$265K 0.01% 936
2016
Q3
$32.5M Buy
673,127
+73,571
+12% +$3.55M 0.01% 954
2016
Q2
$33.2M Buy
599,556
+34,336
+6% +$1.9M 0.01% 923
2016
Q1
$30.2M Buy
565,220
+26,690
+5% +$1.42M 0.01% 952
2015
Q4
$27.7M Buy
538,530
+45,930
+9% +$2.36M 0.01% 983
2015
Q3
$22.2M Buy
492,600
+50,600
+11% +$2.29M ﹤0.01% 1046
2015
Q2
$20.4M Buy
442,000
+27,600
+7% +$1.28M ﹤0.01% 1128
2015
Q1
$17.8M Buy
414,400
+16,200
+4% +$695K ﹤0.01% 1174
2014
Q4
$13.8M Sell
398,200
-5,400
-1% -$187K ﹤0.01% 1233
2014
Q3
$13.1M Buy
403,600
+7,900
+2% +$256K ﹤0.01% 1233
2014
Q2
$13.4M Buy
395,700
+27,300
+7% +$925K ﹤0.01% 1242
2014
Q1
$10M Buy
368,400
+7,200
+2% +$196K ﹤0.01% 1303
2013
Q4
$12.9M Buy
361,200
+19,900
+6% +$712K ﹤0.01% 1216
2013
Q3
$10.3M Buy
341,300
+22,300
+7% +$672K ﹤0.01% 1264
2013
Q2
$9.3M Buy
+319,000
New +$9.3M ﹤0.01% 1269